Amgen Inc.
Treatment of asthma with anti-TSLP antibody
Last updated:
Abstract:
The present disclosure, relates, in general, to methods of treating asthma, including severe asthma and eosinophilic asthma, using an antibody specific for thymic stromal lymphopoietin (TSLP).
Status:
Grant
Type:
Utility
Filling date:
12 Apr 2018
Issue date:
10 Nov 2020